Redhill Biopharma Ltd (NASDAQ:RDHL)

5.01
Delayed Data
As of 11:26am ET
 +0.191 / +3.96%
Today’s Change
4.30
Today|||52-Week Range
11.25
-2.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues6.9M3.0K101.3K4.0M
 
 
 
 
 
Cost of Goods Sold1.0M0.00--2.1M
 
 
 
Depreciation And Amortization26.6K36.0K44.1K81.6K
 
 
 
 
 
 
Operating ExpensesGross Income5.9M-33.0K--1.9M
 
 
 
 
General Expenses16.5M21.9M30.7M53.4M
 
 
 
 
 
Research And Development12.5M17.8M25.3M33.2M
 
 
 
 
 
Total Operating Expenses17.5M21.9M30.7M55.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.6M-21.9M-30.6M-51.5M
 
 
 
 
 
Extraordinary Credit197.2K887.7K1.2M5.7M
 
 
 
 
 
Extraordinary Charge---100.0K-369.2K-851.0K
 
 
 
 
Other Expenses-279.0K-211.9K27.1K447.2K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.6M-21.1M-29.5M-45.9M
 
 
 
 
 
Net Income-10.6M-21.1M-29.5M-45.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS8.7M11.1M12.9M17.7M
 
 
 
 
 
Shares To Calculate EPS Diluted8.7M11.2M12.9M17.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.18-$1.90-$2.31-$2.62
 
 
 
 
 
EPS Diluted-$1.28-$1.90-$2.41-$2.62